GlobeNewswire: Children's Tumor Foundation Contains the last 10 of 6 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T12:14:08ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2014/06/09/642724/10085014/en/Media-Alert-Innovative-Business-Opportunities-in-Neurofibromatosis.html?f=22&fvtc=4&fvtv=20806Media Alert: Innovative Business Opportunities in Neurofibromatosis2014-06-09T14:19:57Z<![CDATA[Leading Industry Experts and Investors to Outline Unique Opportunities in NF Research NEW YORK, N.Y., June 9, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor Foundation (CTF) is hosting the 2014 NF Conference, the largest worldwide meeting dedicated entirely to neurofibromatosis (NF), a genetic disorder that affects one in 3,000 people and can cause tumors to grow anywhere in the body. Media is invited to cover a unique 'satellite meeting' taking place concurrently with the NF Conference.]]>https://www.globenewswire.com/news-release/2014/06/06/642451/10084887/en/KEY-MEDIA-OPPORTUNITIES-AT-THE-2014-NF-FORUM-CONFERENCE.html?f=22&fvtc=4&fvtv=20806KEY MEDIA OPPORTUNITIES AT THE 2014 NF FORUM/CONFERENCE2014-06-06T20:54:57Z<![CDATA[
-- NIH Director Francis Collins to Deliver Keynote Address ]]>https://www.globenewswire.com/news-release/2014/06/03/641604/10084431/en/World-s-Largest-Neurofibromatosis-Conference-to-be-Held-in-Washington-D-C.html?f=22&fvtc=4&fvtv=20806World's Largest Neurofibromatosis Conference to be Held in Washington, D.C.2014-06-03T20:52:25Z<![CDATA[NF Conference and NF Forum at the Omni Shoreham Hotel -- June 6-10, 2014 NEW YORK, June 3, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor Foundation (CTF) is hosting the 2014 NF Conference/Forum, the largest worldwide meeting dedicated entirely to neurofibromatosis (NF), a genetic disorder that affects one in 3,000 people and can cause tumors to grow anywhere in the body. These tumors may result in serious health issues including vision and hearing loss, learning disabilities, and intense pain. The Children's Tumor Foundation is the leading nonprofit organization dedicated to funding research into treatments for NF, for which there currently is no cure.]]>https://www.globenewswire.com/news-release/2014/03/14/618448/10072662/en/Alzheimer-s-Drug-Discovery-Foundation-and-Children-s-Tumor-Foundation-announce-Partnership-to-Provide-Drug-Discovery-Resources-for-Research-Community.html?f=22&fvtc=4&fvtv=20806Alzheimer's Drug Discovery Foundation and Children's Tumor Foundation announce Partnership to Provide Drug Discovery Resources for Research Community2014-03-14T14:31:23Z<![CDATA[NEW YORK, N.Y., March 14, 2014 (GLOBE NEWSWIRE) -- The ]]>deschttps://www.globenewswire.com/news-release/2014/03/10/617113/10071956/en/Children-s-Tumor-Foundation-Announces-Historic-New-Initiative-in-Neurofibromatosis-Research.html?f=22&fvtc=4&fvtv=20806Children's Tumor Foundation Announces Historic New Initiative in Neurofibromatosis Research2014-03-10T15:33:14Z<![CDATA['Dream Team' of Scientists Collaborate in Unique NF Research Consortium NEW YORK, March 10, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor Foundation, the leading non-governmental organization dedicated to neurofibromatosis (NF) research, announced today an important new research collaboration called Synodos, a first-of-its-kind initiative dedicated to defeating the rare genetic disorder neurofibromatosis type 2 (NF2). This unique consortium brings together a multidisciplinary team of scientists from twelve world-class labs at academic and medical centers of excellence, who have pledged to work closely together – sharing information, datasets, results and more – at every step in research development, with the goal of speeding up the drug discovery process.]]>deschttps://www.globenewswire.com/news-release/2014/01/15/602707/10064374/en/Children-s-Tumor-Foundation-Announces-Leadership-Change.html?f=22&fvtc=4&fvtv=20806Children's Tumor Foundation Announces Leadership Change2014-01-15T19:16:10Z<![CDATA[Annette Bakker, PhD named President of the Foundation NEW YORK, Jan. 15, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor Foundation (CTF) announced today that Annette Bakker, Chief Scientific Officer of the Foundation has been elevated to President, succeeding outgoing President John W. Risner. A highly-regarded expert with vast experience in research and drug discovery, Dr. Bakker assumes the position of President immediately. In her new role, Dr. Bakker will be responsible for all facets of the Foundation's strategic initiatives and operations, including program development, fundraising, research, and public outreach. Along with her new responsibilities, she will also continue to serve as the Foundation's Chief Scientific Officer.]]>Annette Bakker